Product label warns not to use the product if heat cell contents leak and/or the wrap is damaged or torn.
ThermaCare Muscle Pain Therapy provides heat therapy for temporary relief of minor muscular aches and pains associated with overexertion, strains, sprains, and arthritis. ThermaCare Menstrual Pain Therapy provides heat therapy for temporary relief of minor menstrual cramp pain and associated backaches.
The ThermaCare HeatWrap lots impacted are S68516 (Muscle Pain Therapy 3+1 count carton), T26686 (Muscle Pain Therapy 3 count carton), T26691 (Menstrual Pain Therapy 3 count carton), T26693 (Menstrual Pain Therapy 3+1 count carton); and 8054HA and 8054HB (11 count bundled packages contain one (1) package of Muscle Therapy Heatwraps, 8HR (3 Count) and two (2) packages of Joint Therapy Heatwraps, 8HR (4 Count)).
ThermaCare Joint Therapy Heatwraps, 8HR are not subject to this recall notification, according to Pfizer.
According to Pfizer Consumer Healthcare, it had already notified its retailers of this recall on Oct. 2, 2018 and has provided instructions for the return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lot being recalled should stop use and distribution and quarantine the product immediately. Wholesalers, distributors and retailers who have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them.
Pfizer Consumer Healthcare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to discontinue use of the products, record the lot number, throw the product away in its entirety without opening the foil pouch, and to please contact the Pfizer Consumer Healthcare Information Line for replacement or reimbursement.